Tilray Brands (TLRY) Competitors

C$7.80 -0.28 (-3.47%)

As of 04:00 PM Eastern

TLRY vs. BHC, SLS, AUP, CARA, and CRON

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Bausch Health Companies (BHC), Solaris Resources (SLS), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry.

How does Tilray Brands compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Tilray Brands (TSE:TLRY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

: Bausch Health Companies has a net margin of -13.54% compared to Tilray Brands' net margin of -158.75%. Bausch Health Companies' return on equity of 120.43% beat Tilray Brands' return on equity.
Company Net Margins Return on Equity Return on Assets
Bausch Health Companies -13.54% 120.43% 4.16%
Tilray Brands -158.75% -88.06% -1.41%
: In the previous week, Bausch Health Companies had 1 more articles in the media than Tilray Brands. MarketBeat recorded 4 mentions for Bausch Health Companies and 3 mentions for Tilray Brands. Tilray Brands' average media sentiment score of 0.36 beat Bausch Health Companies' score of 0.22 indicating that Tilray Brands is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch Health Companies
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Bausch Health Companies has higher revenue and earnings than Tilray Brands. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bausch Health Companies C$10.53B 0.27 -C$125.65M -C$3.24 N/A
Tilray Brands C$858.28M 1.09 -C$183.24M -C$14.63 N/A
: Bausch Health Companies has a beta of 0.588188, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 3.243166, suggesting that its share price is 224% more volatile than the S&P 500.
: 13.5% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 4.1% of Tilray Brands shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by insiders. Comparatively, 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 70.51%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Bausch Health Companies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
Tilray Brands
0 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Tilray Brands	-158.75%	-88.06%	-1.41%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch Health Companies	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tilray Brands	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.27	-C$125.65M	-C$3.24	N/A
Tilray Brands	C$858.28M	1.09	-C$183.24M	-C$14.63	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Bausch Health Companies beats Tilray Brands on 9 of the 14 factors compared between the two stocks.

How does Tilray Brands compare to Solaris Resources?

Solaris Resources (TSE:SLS) and Tilray Brands (TSE:TLRY) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

: 16.1% of Solaris Resources shares are owned by institutional investors. Comparatively, 4.1% of Tilray Brands shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by insiders. Comparatively, 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
: Solaris Resources has higher earnings, but lower revenue than Tilray Brands. Solaris Resources is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Solaris Resources N/A N/A -C$46.49M -C$0.26 N/A
Tilray Brands C$858.28M 1.09 -C$183.24M -C$14.63 N/A
: Solaris Resources has a beta of 1.845161, meaning that its share price is 85% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 3.243166, meaning that its share price is 224% more volatile than the S&P 500.
: Solaris Resources presently has a consensus price target of C$19.50, indicating a potential upside of 47.17%. Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 70.51%. Given Tilray Brands' higher probable upside, analysts plainly believe Tilray Brands is more favorable than Solaris Resources.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
Tilray Brands
0 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Solaris Resources has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Solaris Resources' return on equity of 96.23% beat Tilray Brands' return on equity.
Company Net Margins Return on Equity Return on Assets
Solaris Resources N/A 96.23% -51.67%
Tilray Brands -158.75% -88.06% -1.41%
: In the previous week, Tilray Brands had 2 more articles in the media than Solaris Resources. MarketBeat recorded 3 mentions for Tilray Brands and 1 mentions for Solaris Resources. Solaris Resources' average media sentiment score of 0.48 beat Tilray Brands' score of 0.36 indicating that Solaris Resources is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solaris Resources
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.26	N/A
Tilray Brands	C$858.28M	1.09	-C$183.24M	-C$14.63	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	96.23%	-51.67%
Tilray Brands	-158.75%	-88.06%	-1.41%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solaris Resources	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tilray Brands	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Solaris Resources beats Tilray Brands on 9 of the 15 factors compared between the two stocks.

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals (TSE:AUP) and Tilray Brands (TSE:TLRY) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

: 4.1% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
: Tilray Brands has higher revenue and earnings than Aurinia Pharmaceuticals. Tilray Brands is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aurinia Pharmaceuticals C$57.59M 0.00 -C$190.03M -C$1.48 N/A
Tilray Brands C$858.28M 1.09 -C$183.24M -C$14.63 N/A
: Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 70.51%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Aurinia Pharmaceuticals.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurinia Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Tilray Brands
0 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Aurinia Pharmaceuticals has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Tilray Brands' return on equity.
Company Net Margins Return on Equity Return on Assets
Aurinia Pharmaceuticals N/A N/A N/A
Tilray Brands -158.75% -88.06% -1.41%
: In the previous week, Tilray Brands had 3 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 3 mentions for Tilray Brands and 0 mentions for Aurinia Pharmaceuticals. Tilray Brands' average media sentiment score of 0.36 beat Aurinia Pharmaceuticals' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.
Company Overall Sentiment
Aurinia Pharmaceuticals Neutral
Tilray Brands Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A
Tilray Brands	C$858.28M	1.09	-C$183.24M	-C$14.63	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
Aurinia Pharmaceuticals	N/A	N/A	N/A
Tilray Brands	-158.75%	-88.06%	-1.41%

Company	Overall Sentiment
Aurinia Pharmaceuticals	Neutral
Tilray Brands	Neutral

Summary

Tilray Brands beats Aurinia Pharmaceuticals on 9 of the 13 factors compared between the two stocks.

How does Tilray Brands compare to Cara Operations?

Cara Operations (TSE:CARA) and Tilray Brands (TSE:TLRY) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

: 4.1% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
: Cara Operations has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Cara Operations' return on equity of 0.00% beat Tilray Brands' return on equity.
Company Net Margins Return on Equity Return on Assets
Cara Operations N/A N/A N/A
Tilray Brands -158.75% -88.06% -1.41%
: In the previous week, Tilray Brands had 3 more articles in the media than Cara Operations. MarketBeat recorded 3 mentions for Tilray Brands and 0 mentions for Cara Operations. Tilray Brands' average media sentiment score of 0.36 beat Cara Operations' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.
Company Overall Sentiment
Cara Operations Neutral
Tilray Brands Neutral
: Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 70.51%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Cara Operations.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cara Operations
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Tilray Brands
0 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Cara Operations has higher earnings, but lower revenue than Tilray Brands.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cara Operations N/A N/A N/A N/A N/A
Tilray Brands C$858.28M 1.09 -C$183.24M -C$14.63 N/A

Company	Net Margins	Return on Equity	Return on Assets
Cara Operations	N/A	N/A	N/A
Tilray Brands	-158.75%	-88.06%	-1.41%

Company	Overall Sentiment
Cara Operations	Neutral
Tilray Brands	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cara Operations	N/A	N/A	N/A	N/A	N/A
Tilray Brands	C$858.28M	1.09	-C$183.24M	-C$14.63	N/A

Summary

Tilray Brands beats Cara Operations on 7 of the 10 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Tilray Brands (TSE:TLRY) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

: Tilray Brands presently has a consensus price target of C$13.30, suggesting a potential upside of 70.51%. Cronos Group has a consensus price target of C$4.38, suggesting a potential upside of 21.53%. Given Tilray Brands' higher probable upside, equities research analysts clearly believe Tilray Brands is more favorable than Cronos Group.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
Cronos Group
0 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
3.00
: 4.1% of Tilray Brands shares are held by institutional investors. Comparatively, 4.4% of Cronos Group shares are held by institutional investors. 0.7% of Tilray Brands shares are held by company insiders. Comparatively, 46.4% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
: Tilray Brands has a beta of 3.243166, suggesting that its stock price is 224% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.036621, suggesting that its stock price is 4% more volatile than the S&P 500.
: In the previous week, Tilray Brands had 2 more articles in the media than Cronos Group. MarketBeat recorded 3 mentions for Tilray Brands and 1 mentions for Cronos Group. Tilray Brands' average media sentiment score of 0.36 beat Cronos Group's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cronos Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Cronos Group has a net margin of -6.37% compared to Tilray Brands' net margin of -158.75%. Cronos Group's return on equity of -0.87% beat Tilray Brands' return on equity.
Company Net Margins Return on Equity Return on Assets
Tilray Brands -158.75% -88.06% -1.41%
Cronos Group -6.37% -0.87% -3.73%
: Cronos Group has lower revenue, but higher earnings than Tilray Brands. Cronos Group is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tilray Brands C$858.28M 1.09 -C$183.24M -C$14.63 N/A
Cronos Group C$146.59M 9.24 -C$32.78M -C$0.02 N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cronos Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Cronos Group	-6.37%	-0.87%	-3.73%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	1.09	-C$183.24M	-C$14.63	N/A
Cronos Group	C$146.59M	9.24	-C$32.78M	-C$0.02	N/A

Summary

Cronos Group beats Tilray Brands on 9 of the 16 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TLRY vs. The Competition

Export

Metric	Tilray Brands	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$932.91M	C$1.63B	C$6.25B	C$11.72B
Dividend Yield	N/A	2.97%	2.73%	6.22%
P/E Ratio	-0.53	4.18	29.04	23.83
Price / Sales	1.09	1,488.53	476.61	13.46
Price / Cash	5.95	10.37	27.62	82.69
Price / Book	0.58	10.72	9.67	4.48
Net Income	-C$183.24M	C$21.15B	C$3.55B	C$300.68M
7 Day Performance	-12.95%	-1.18%	1.70%	0.12%
1 Month Performance	-14.75%	0.15%	5.62%	2.88%
1 Year Performance	30.00%	24.15%	34.42%	57.78%

Tilray Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TLRY Tilray Brands	1.688 of 5 stars	C$7.80 -3.5%	C$13.30 +70.5%	N/A	C$932.91M	C$858.28M	N/A	2,650
BHC Bausch Health Companies	0.5813 of 5 stars	C$7.66 -1.4%	N/A	N/A	C$2.86B	C$10.27B	18.24	19,900	Earnings Report
SLS Solaris Resources	1.6716 of 5 stars	C$13.51 -2.4%	C$19.50 +44.3%	N/A	C$2.26B	N/A	N/A	10
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume
CARA Cara Operations	N/A	N/A	N/A	N/A	C$1.62B	N/A	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:TLRY) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tilray Brands (TLRY) Competitors

TLRY vs. BHC, SLS, AUP, CARA, and CRON

How does Tilray Brands compare to Bausch Health Companies?

Summary

How does Tilray Brands compare to Solaris Resources?

Summary

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Summary

How does Tilray Brands compare to Cara Operations?

Summary

How does Tilray Brands compare to Cronos Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tilray Brands (TLRY) Competitors

TLRY vs. BHC, SLS, AUP, CARA, and CRON

How does Tilray Brands compare to Bausch Health Companies?

Summary

How does Tilray Brands compare to Solaris Resources?

Summary

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Summary

How does Tilray Brands compare to Cara Operations?

Summary

How does Tilray Brands compare to Cronos Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools